Results for the Inactivated Whole Virus vaccine by Wuhan Institute of Biological Products Phase II Trial
- Safety Outcomes
- Immunogenicity Outcomes
0
1
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Learn After
Safety Outcomes for the Inactivated Whole Virus Vaccine by Wuhan Institute of Biological Products Phase II Trial
Immunogenicity Outcomes for the Inactivated Whole Virus Vaccine by Wuhan Institute of Biological Products Phase II Trial
Figure 3. Antibody Responses 14 Days After the Second Dose in the Phase 2 Trial
Wuhan Institute of Biological Products Vaccine Specifics (phases 1+2)
Learn After
Safety Outcomes for the Inactivated Whole Virus Vaccine by Wuhan Institute of Biological Products Phase II Trial
Immunogenicity Outcomes for the Inactivated Whole Virus Vaccine by Wuhan Institute of Biological Products Phase II Trial
Figure 3. Antibody Responses 14 Days After the Second Dose in the Phase 2 Trial
Wuhan Institute of Biological Products Vaccine Specifics (phases 1+2)